Ekarpen to invest EUR12.5 million in Progenika Biopharma - MarketLine Financial Deals

Ekarpen to invest EUR12.5 million in Progenika Biopharma

Ekarpen to invest EUR12.5 million in Progenika Biopharma - MarketLine Financial Deals
Ekarpen to invest EUR12.5 million in Progenika Biopharma
Published Sep 01, 2011
2 pages — Published Sep 01, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Ekarpen SPE SA, an investment firm, has entered into an investment agreement with Progenika Biopharma, S.A.

  
Source:
Document ID
MA78993_110909
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Ekarpen to invest EUR12.5 million in Progenika Biopharma" Sep 01, 2011. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ekarpen-to-invest-EUR12-5-million-in-Progenika-Biopharma-2052-68530>
  
APA:
MarketLine Financial Deals. (2011). Ekarpen to invest EUR12.5 million in Progenika Biopharma Sep 01, 2011. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ekarpen-to-invest-EUR12-5-million-in-Progenika-Biopharma-2052-68530>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.